Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from NATCO Pharma Limited ( (IN:NATCOPHARM) ).
Natco Pharma Limited has announced the appointment of Mr. Bhimrao Dattu Jadhav as the Senior Vice President of Operations (Formulations) for its Pharma Division in Kothur, effective March 3, 2025. Mr. Jadhav brings over 30 years of experience in pharmaceutical operations management, having previously held senior positions at INTAS Pharmaceutical Laboratories Ltd and Dr. Reddy’s Labs. This strategic appointment is expected to enhance Natco Pharma’s operational capabilities and strengthen its position in the pharmaceutical industry.
More about NATCO Pharma Limited
Natco Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of generic drugs and formulations. The company is known for its emphasis on providing affordable medications and has a significant presence in both domestic and international markets.
YTD Price Performance: -44.74%
Average Trading Volume: 58,047
Current Market Cap: 138.2B INR
For an in-depth examination of NATCOPHARM stock, go to TipRanks’ Stock Analysis page.